10X Genomics Inc
NASDAQ:TXG

Watchlist Manager
10X Genomics Inc Logo
10X Genomics Inc
NASDAQ:TXG
Watchlist
Price: 22.96 USD -0.99% Market Closed
Market Cap: $2.9B

Net Margin

-11.9%
Current
Improving
by 18.4%
vs 3-y average of -30.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-11.9%
=
Net Income
$-76.3m
/
Revenue
$641.8m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-11.9%
=
Net Income
$-76.3m
/
Revenue
$641.8m

Peer Comparison

Country Company Market Cap Net
Margin
US
10X Genomics Inc
NASDAQ:TXG
2.9B USD
Loading...
US
PerkinElmer Inc
LSE:0KHE
1.3T USD
Loading...
US
Thermo Fisher Scientific Inc
NYSE:TMO
236.9B USD
Loading...
US
Danaher Corp
NYSE:DHR
165.5B USD
Loading...
CH
Lonza Group AG
SIX:LONN
37.6B CHF
Loading...
US
IQVIA Holdings Inc
NYSE:IQV
40.1B USD
Loading...
CN
WuXi AppTec Co Ltd
SSE:603259
279.2B CNY
Loading...
US
Agilent Technologies Inc
NYSE:A
38.2B USD
Loading...
KR
Samsung Biologics Co Ltd
KRX:207940
46.3T KRW
Loading...
US
Mettler-Toledo International Inc
NYSE:MTD
28.8B USD
Loading...
FR
Sartorius Stedim Biotech SA
PAR:DIM
20.3B EUR
Loading...

Market Distribution

Lower than 71% of companies in the United States of America
Percentile
29th
Based on 15 072 companies
29th percentile
-11.9%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

10X Genomics Inc
Glance View

10X Genomics Inc. stands as a beacon of innovation in the rapidly evolving field of genomics, where the frontier of scientific discovery meets commercial enterprise. Founded in 2012, the company emerged from a vision to delve deeper into the cellular universe, offering tools that illuminate the complexities of biological systems. Nestled in the heart of Silicon Valley, the company has harnessed cutting-edge technology to develop platforms that enable scientists to observe cellular behavior with unprecedented clarity and detail. These tools are particularly vital for understanding the nuances of diseases and developing more targeted therapeutic interventions. At its core, 10X Genomics specializes in creating sophisticated single-cell and spatial analysis solutions, which allow researchers to dissect the minutiae of genetic information within individual cells—an advancement that traditional bulk sequencing techniques simply cannot achieve. This innovative approach is not just a scientific marvel but a robust business model that thrives on the burgeoning demand for advanced genomic research. 10X Genomics generates revenue through a blend of product sales and services. Its primary offerings include instruments and proprietary consumables, such as reagent kits that are fundamental to extracting actionable insights from genomic data. The company’s unique Chromium and Visium platforms are sought after by academic institutions, pharmaceutical companies, and clinical research organizations worldwide. By coupling high-margin consumables with sophisticated hardware, 10X Genomics ensures a recurring revenue stream that supports sustained growth. Meanwhile, it continues to invest heavily in research and development, ensuring its place at the cutting edge of genomic science and maintaining a competitive advantage in a space that demands relentless innovation.

TXG Intrinsic Value
HIDDEN
Show
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-11.9%
=
Net Income
$-76.3m
/
Revenue
$641.8m
What is 10X Genomics Inc's current Net Margin?

The current Net Margin for 10X Genomics Inc is -11.9%, which is above its 3-year median of -30.3%.

How has Net Margin changed over time?

Over the last 3 years, 10X Genomics Inc’s Net Margin has increased from -33.2% to -11.9%. During this period, it reached a low of -42.3% on Mar 31, 2024 and a high of -11.9% on Sep 30, 2025.

Back to Top